? CORE B Cleveland Clinic has a long-standing commitment and documented success in transitioning laboratory discoveries and clinical innovations into improvements in patient care. Core B was created for the TPPG Cycle II in order to enhance and coordinate the outstanding Cleveland Clinic resources, and rapidly advance the strong pipeline of early stage laboratory discoveries and technical innovations that have been generated in Cycle I of the TPPG to commercialization. Core B will work in synergy with the project teams to validate and transition the technologies by providing access to drug discovery and development resources, project management support, and skills development. The Core will leverage the facilities available at Cleveland Clinic Innovations (CCI), NIH Center for Accelerated Innovations at Cleveland Clinic (NCAI-CC) funded by NHLBI, and the NSF funded Innovations-Corps Hub at Cleveland Clinic to promote the development of these innovative projects through experienced project management and accelerated skills development. Core B will facilitate the interactions with the established industry partners (Procter & Gamble, Nestle, Bayer, Ironwood, Cleveland HeartLab, Wuxi, Novartis, and Johnson & Johnson) to insure rapid development of the projects. The overall goal of Technology Development and Commercialization Core (Core B) of the TPPG is to establish the needed organization to accelerate the current technologies from early-stage to commercialization, and engage TPPG investigators to be full partners in transforming their discoveries into high-impact advances in patient care.
The Specific Aims i nclude: To establish the resources necessary for translating research into advanced solutions for improving asthma patient care (aim 1); To offer expert project management guidance to the project teams (aim 2), and; To provide new and existing diverse resources to educate and mentor our project researchers including basic, translational, and clinical scientists in biomedical innovation and entrepreneurism (aim 3). All projects will utilize Core B resources.

Public Health Relevance

? CORE B The Technology Development and Commercialization Core B provides critical intellectual support for the development for all the translational projects in the program. The resources include access to commercial vendors to support the execution and implementation of the discovery commercialization steps. Core B complements the scientific efforts by providing training to investigators on skills needed to attract and enhance partners needed to commercialize their innovations.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL103453-09
Application #
9766943
Study Section
Special Emphasis Panel (ZHL1)
Program Officer
Noel, Patricia
Project Start
Project End
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
9
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Herjan, Tomasz; Hong, Lingzi; Bubenik, Jodi et al. (2018) IL-17-receptor-associated adaptor Act1 directly stabilizes mRNAs to mediate IL-17 inflammatory signaling. Nat Immunol 19:354-365
Sweeny, Elizabeth A; Singh, Anuradha Bharara; Chakravarti, Ritu et al. (2018) Glyceraldehyde-3-phosphate dehydrogenase is a chaperone that allocates labile heme in cells. J Biol Chem 293:14557-14568
Reichard, Andrew; Wanner, Nicholas; Stuehr, Eric et al. (2018) Quantification of airway fibrosis in asthma by flow cytometry. Cytometry A 93:952-958
Asosingh, Kewal; Weiss, Kelly; Queisser, Kimberly et al. (2018) Endothelial cells in the innate response to allergens and initiation of atopic asthma. J Clin Invest 128:3116-3128
Reichard, Andrew; Asosingh, Kewal (2018) The role of mitochondria in angiogenesis. Mol Biol Rep :
Yang, Hui; Zhu, Yun; Chen, Xing et al. (2018) Structure of a prokaryotic SEFIR domain reveals two novel SEFIR-SEFIR interaction modes. J Struct Biol 203:81-89
Cai, Gang; Zhu, Liang; Chen, Xing et al. (2018) TRAF4 binds to the juxtamembrane region of EGFR directly and promotes kinase activation. Proc Natl Acad Sci U S A 115:11531-11536
Zein, Joe G; Love, Thomas E; Erzurum, Serpil C (2017) Asthma Is Associated with a Lower Risk of Sepsis and Sepsis-related Mortality. Am J Respir Crit Care Med 196:787-790
Zepp, Jarod A; Zhao, Junjie; Liu, Caini et al. (2017) IL-17A-Induced PLET1 Expression Contributes to Tissue Repair and Colon Tumorigenesis. J Immunol 199:3849-3857
Stober, Vandy P; Johnson, Collin G; Majors, Alana et al. (2017) TNF-stimulated gene 6 promotes formation of hyaluronan-inter-?-inhibitor heavy chain complexes necessary for ozone-induced airway hyperresponsiveness. J Biol Chem 292:20845-20858

Showing the most recent 10 out of 136 publications